Michael Noderer is an Associate Principal Scientist within the AstraZeneca Device Development group. Michael holds a Diplom Ingenieur degree in Mechanical Engineering and a MEng. He spent the last 15 years of his career in device development. During this time, he led projects through all phases of product design, from early feasibility studies to design transfer and regulatory submissions. Michael was the technical lead in the development of Sanofi’s Lyxumia/Adlyxin and Toujeo devices before he joint AstraZeneca where he completed the development activities for Bydureon autoinjector which was successfully launched in US 2018.